NLRP3 and asthma: Similarly, NLRP3 inhibition attenuated bronchial inflammation and hyperresponsiveness in asthma mouse models induced by house dust mite (HDM) or toluene diisocyanate (TDI) (Ma et al., 2021; Zhuang et al., 2020).